{
    "eid": "2-s2.0-85011633843",
    "title": "Characteristics and outcomes of adult outpatients with heart failure and improved or recovered ejection fraction",
    "cover-date": "2016-08-01",
    "subject-areas": [
        {
            "$": "Cardiology and Cardiovascular Medicine",
            "@code": "2705"
        }
    ],
    "keywords": [],
    "authors": [
        "Andreas P. Kalogeropoulos"
    ],
    "citedby-count": 196,
    "ref-count": 30,
    "ref-list": [
        "Trends in prevalence and outcome of heart failure with preserved ejection fraction",
        "Systolic and diastolic heart failure in the community",
        "Contemporary prevalence and correlates of incident heart failure with preserved ejection fraction",
        "Heart failure with preserved left ventricular systolic function: A hospital cohort study",
        "Outcome of heart failure with preserved ejection fraction in a population-based study",
        "Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure",
        "Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: Prevalence, therapies, and outcomes",
        "Prevalence, clinical characteristics, and outcomes associated with eccentric versus concentric left ventricular hypertrophy in heart failure with preserved ejection fraction",
        "Heart failure with preserved ejection fraction: A heterogenous disorder with multifactorial pathophysiology",
        "Cardiac structure and function in heart failure with preserved ejection fraction: Baseline findings from the echocardiographic study of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial",
        "2013 ACCF/AHA guideline for the management of heart failure: A report of the american college of cardiology foundation/american heart association task force on practice guidelines",
        "Heart failure with recovered ejection fraction: A distinct clinical entity",
        "Heart failure with recovered ejection fraction clinical description, biomarkers, and outcomes",
        "Heart Failure (HF): Algorithm for Measures Calculation: EHRS",
        "Chronic Conditions Data Warehouse: Condition Categories",
        "HCUP Clinical Classifications Software (CCS) for ICD-9-CM",
        "Eplerenone in patients with systolic heart failure and mild symptoms: Analysis of repeat hospitalizations",
        "Letter by Psaty et al regarding article, \"heart failure with recovered ejection fraction: Clinical description, biomarkers, and outcomes\"",
        "Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: Quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE)",
        "How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with \"sCD-HeFT Criteria?\"",
        "Long-term functional and clinical follow-up of patients with heart failure with recovered left ventricular ejection fraction after \u03b2-blocker therapy",
        "Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: Findings from IMPROVE HF",
        "Outcome of congestive heart failure in elderly persons: Influence of left ventricular systolic function. The cardiovascular health study",
        "Left ventricular inotropic reserve and right ventricular function predict increase of left ventricular ejection fraction after beta-blocker therapy in nonischemic cardiomyopathy",
        "Synergistic polymorphisms of \u03b21 and \u03b12C-adrenergic receptors and the influence on left ventricular ejection fraction response to \u03b2-blocker therapy in heart failure",
        "Impact of left ventricular size on pharmacologic reverse remodeling in heart failure",
        "Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype",
        "The influence of left ventricular ejection fraction on the effectiveness of cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy)",
        "Adrenergic receptor gene polymorphism and left ventricular reverse remodelling after cardiac resynchronization therapy: Preliminary results",
        "Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction"
    ],
    "affiliation": [
        {
            "affiliation-city": "Atlanta",
            "affilname": "Emory University School of Medicine",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Los Angeles",
            "affilname": "Ronald Reagan UCLA Medical Center",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Stony Brook",
            "affilname": "Stony Brook University",
            "affiliation-country": "United States"
        }
    ],
    "funding": []
}